S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer

This study provides novel insights that S1PR2 inhibitors could sensitize 5-FU therapy in colorectal cancer.Graphical abstract
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research